Lantheus Holdings, Inc.

Healthcare

NASDAQ:LNTH · NASDAQ Global Market

Market Cap $6.80B Beta -0.04 P/E (TTM) 24.2

$104.52 +0.19%

+$0.20 today

52W Low $47.25High $104.57

Vol 0.69M · Avg 0.94M

EPS (TTM)$4.31

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+34.29%

Period High

$104.52

Period Low

$50.11

Latest

$104.52

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

$5.64B

Amneal Pharmaceuticals, Inc.

NASDAQ:AMRX

$5.17B

Hinge Health, Inc.

NYSE:HNGE

$5.06B

Indivior Pharmaceuticals Inc

NASDAQ:INDV

$4.80B

Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

$3.63B

ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

$3.61B

Supernus Pharmaceuticals, Inc.

NASDAQ:SUPN

$2.58B

HUTCHMED (China) Limited

NASDAQ:HCM

$1.91B

ADMA Biologics, Inc.

NASDAQ:ADMA

$1.90B

Bausch Health Companies Inc.

NYSE:BHC

$1.89B

What is the latest LNTH filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does LNTH have?

Intrinsic Alpha currently shows 20 recent filings for LNTH.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.